RECENT ADVANCES IN CHEMOTHERAPY FOR LYMPHOMA OF DOGS AND CATS

Highly successful combination chemotherapeutic protocols have now been developed for dogs and cats with lymphoma, thereby making attainment of durable remissions (i.e., those lasting longer than six months) the norm rather than the exception. Attaining durable second and third re missions through rescue therapy, however, remains an elusive goal. Thi s article discusses recent investigations attempting to improve the ef ficacy and lessen the toxicity of current drugs in use. Recent investi gations on rescue protocols that strive to achieve durable second remi ssions are also presented.